טוען...
Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer
INTRODUCTION: Treatment of advancing prostate cancer focuses on blocking the activation of the androgen receptor with resultant prolonged perturbation of the hypothalamic-pituitary-gonadal axis. Androgen deprivation therapy (ADT) is marked, however, by eventual progression to castration- resistant p...
שמור ב:
| הוצא לאור ב: | Can Urol Assoc J |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Canadian Medical Association
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455620/ https://ncbi.nlm.nih.gov/pubmed/26085869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2545 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|